Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
For full access to this article login to GEN Select now.
Seizing Immunoassay Opportunities
Growth Prospects—Flecks of Hidden Gold—Still Occur in an Otherwise Mature Market
- At first glance, the immunoassay market would seem to offer little to healthcare marketers or investors seeking high revenue growth opportunities. Immunoassays are, frankly, an older category of tests. The first tests were launched in the 1960s. Some of the companies of that era still operate, though under different ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.